Vanderbilt-Ingram Cancer Center accrued the most patients nationwide for the clinical trial for P-BCMA-ALLO1 – a chimeric antigen receptor T cell therapy (CAR-T) derived from healthy donors’ white blood cells.

Evidence showed that deficiency in musical rhythm perception is a “modest but consistent risk factor for developmental speech, language and reading disorders.”

These raised scars tend to recur after surgical removal, and the effectiveness of alternative treatments is limited.

A new study identified a safe and effective fluorescent imaging agent that can assist surgeons in visualizing — and therefore protecting — nerves during surgery.

These new technologies showcase how VUMC researchers are using the power of AI to meet a wide range of medical needs.

The research is another step toward development of targeted therapies aimed at reducing the incidence and medical burden of this common condition.

Single-cell analysis reveals the inner workings of the life-threatening adverse drug reactions Stevens-Johnson syndrome and toxic epidermal necrolysis.